Sushrut S. Waikar MD
Section Chief, Nephrology
Norman G. Levinsky Professor, Nephrology
650 Albany St | (617) 638-7330swaikar@bu.edu
Sections
Nephrology
Biography
Sushrut S. Waikar, MD, MPH received a BA in English and Neuroscience at Amherst College, his MD at Yale, and an MPH at Harvard. He is the Norman G. Levinsky Professor of Medicine at Chobanian and Avedisian School of Medicine and Chief of Nephrology at Boston Medical Center. Dr. Waikar's research interests and active projects include epidemiologic, translational, and interventional studies to address novel and clinically important questions in nephrology. Current areas of investigation include optimal diagnostic testing in acute kidney injury and chronic kidney disease; biomarkers of kidney pathology and kidney fibrosis; the identification of relevant targets for interventional trials in kidney disease; and randomized controlled trials. He is a Principal Investigator of several NIH grants including the Kidney Precision Medicine Project (U01 DK133092), Multi-omics and Chronic Kidney Disease: Correlation with Histology (R01 DK108803), Discovery Science Collaborative for CKDu (U01 DK130060), NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial (U01AG076789) andThe Boston University Kidney and Medical Engineering Program (BU-KIDMEP, R25 DK128858).
Education
MD, Yale University
MPH, Harvard School of Public Health
English/Neuroscience/Neurology, BA, Amherst College
Publications
Tsai MT, Li SY, Kim D, Park J, Schmidt IM, Zhao R, Waikar SS, Hsieh TH, Yang H, Chen TH, Ou SM, Yang RB. Galectin-9 as a circulating marker of mesangial injury and prognosis in biopsy-proven kidney disease. Am J Nephrol. 2026 Jul 29; 1-24. PMID: 42525588.
Published on 7/27/2026Moritz ML, Ciapponi A, Hsu CY, Nigwekar SU, Singhal AB, Rhee CM, Kalantar-Zadeh K, Waikar S, Kovesdy CP, Ayus JC. Hyponatremia treatment guidelines: a necessary course correction. Kidney Int. 2026 Jul 27. PMID: 42535992.
Published on 6/17/2026Chrysopoulou M, de la Rosa X, Tan Y, Kovalenko E, Hahn O, Andersen JF, Lassé M, Matchkov V, Wulfmeyer VC, Jaegers J, Billing AM, Colby E, Bleich M, Schermer B, Kostidis S, Giera M, Peti-Peterdi J, Rhee EP, Grams ME, Waikar SS, Waldman M, Tomas NM, Saleem MA, Himmerkus N, Schmidt IM, Berg P, Demir F, Rinschen MM. Diversion of Arginine's dietary metabolic fate in proteinuric kidney disease. Res Sq. 2026 Jun 17. PMID: 42370251.
Published on 5/29/2026Claudel SE, Waikar SS, Schmidt IM, Verma A. Predictors of Variability in Urine Albumin-to-Creatinine Ratio in the General US Adult Population. Am J Nephrol. 2026 May 29; 1-8. PMID: 42213595.
Published on 5/19/2026Menon R, Kimmel PL, Otto EA, Subramanian L, O'Connor CL, Godfrey B, Smith C, Alakwaa F, Berthier CC, Sarwal MM, Woodle ES, Pyle L, Choi YJ, Ladd P, Sedor JR, Rosas SE, Waikar SS, Naik AS, Melo Ferreira R, Eadon MT, Bitzer M, Bjornstad P, Hodgin JB, Kretzler M. Not all reference samples are equal in single-cell transcriptomics of human kidney tissue. JCI Insight. 2026 May 19. PMID: 42160485.
Published on 4/1/2026Rosan SH, Verma A, Claudel SE, Srivastava A, Palsson R, Stillman IE, Henderson J, Waikar SS, Schmidt IM. Associations of serum uric acid levels with podocyte injury and kidney histopathologic lesions. J Nephrol. 2026 Apr 01. PMID: 41921046.
Published on 3/17/2026Claudel SE, Waikar SS, Scammell MK. An update on the epidemiology of chronic kidney disease of uncertain etiology. Curr Opin Nephrol Hypertens. 2026 May 01; 35(3):353-359. PMID: 41846326.
Published on 3/6/2026Fallegger R, Gomez-Ochoa SA, Boys C, Flores ROR, Tanevski J, Pashos E, Feliers D, Piper M, Schaub JA, Zhou Z, Mao W, Chen X, Sealfon RSG, Menon R, Nair V, Eddy S, Alakwaa FM, Pyle L, Choi YJ, Bjornstad P, Alpers CE, Bitzer M, Bomback AS, Caramori ML, Demeke D, Fogo AB, Herlitz LC, Kiryluk K, Lash JP, Murugan R, O'Toole JF, Palevsky PM, Parikh CR, Rosas SE, Rosenberg AZ, Sedor JR, Vazquez MA, Waikar SS, Wilson FP, Hodgin JB, Barisoni L, Himmelfarb J, Jain S, Ju W, Troyanskaya OG, Kretzler M, Eadon MT, Saez-Rodriguez J. Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification. medRxiv. 2026 Mar 06. PMID: 41822697.
Published on 2/26/2026Claudel SE, Lloyd-Jones DM, Waikar SS, Verma A. Prevalence of Albuminuria Across Cardiovascular-Kidney-Metabolic Phenotypes in the United States. Diabetes Obes Metab. 2026 May; 28(5):4395-4399. PMID: 41749339.
Published on 2/6/2026Djelmami-Hani R, Adebile T, Zhao R, Kwakyi E, Amira O, Omotoso B, Mamven M, Raji YR, Solarin A, Umeizudike T, Eduful E, Olokode BF, Ripiye N, Oluwadare T, Braimoh R, Ijoma C, Mumuni AA, Cozier Y, Quintiliani L, Arogundade F, Salako B, Parekh R, Gbadegesin RA, Dupuis J, Ulasi I, Adu D, Ojo A, Waikar S, Mitchell D, Anderson C, Ilori TO. Beverage patterns, blood pressure, and proteinuria among West Africans with chronic kidney disease: a cross-sectional analysis of the diet, CKD, and apolipoprotein L1 study. Front Nutr. 2026; 13:1724375. PMID: 41727202.
Media Mentions
Published on 7/9/2024
UACR Variability in Type 2 Diabetes Warrants Repeat Testing
Published on 4/7/2023
Kidney biopsy findings predict risk of cardiovascular events in CKD
Published on 3/23/2023
Kidney Biopsy Findings Predict Risk for Cardiovascular Events in CKD
Published on 3/20/2023
Kidney Biopsy Findings Predict Risk of Cardiovascular Events in CKD
Published on 4/15/2021
Existing Race-Based Predictions Can Perpetuate Racism in Nephrology
Published on 8/25/2020
Interpretation of urine sediment tests varies among nephrologists
View full list of 6 media mentions.